Characteristics and impact of drug detailing for gabapentin (Q28469192)

4

object named as

C Seth Landefeld

0 references

author name string

Michael A Steinman

1

0 references

G Michael Harper

2

0 references

Mary-Margaret Chren

Creative Commons CC0 License

3

0 references

language of work or name

English

0 references

publication date

April 2007

0 references

published in

PLOS MEDICINE

0 references

volume

4

0 references

issue

4

0 references

page(s)

e134

0 references

copyright license

start time

24 April 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

For sale: physicians' prescribing data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Interactions between pharmaceutical representatives and doctors in training. A thematic review

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Gabapentin for acute and chronic pain

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Anticonvulsant drugs for migraine prophylaxis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Narrative review: the promotion of gabapentin: an analysis of internal industry documents

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Doctors and drug companies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

A social science perspective on gifts to physicians from industry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Physicians and the pharmaceutical industry: is a gift ever just a gift?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

What information do physicians receive from pharmaceutical representatives?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Characteristics of materials distributed by drug companies. An evaluation of appropriateness

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Interactions between physicians and the pharmaceutical industry: what does the literature say?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Attitudes of general practitioners in New Zealand to pharmaceutical representatives

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Continuing education for general practice and the role of the pharmaceutical industry.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Patterns of preference for information sources in the adoption of new drugs by specialists

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Promotion of prescription drugs to consumers.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Reasons for not seeing drug representatives. They should be seen because they are a good resource

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Principles of educational outreach ('academic detailing') to improve clinical decision making

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Content analysis of drug-detailing by pharmaceutical representatives

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Student understanding of the relationship between the health professions and the pharmaceutical industry.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Assessing the quality of drug detailing.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Commercial detailing techniques used by pharmaceutical representatives to influence prescribing.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners?

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Teaching information mastery: evaluating information provided by pharmaceutical representatives.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Physicians, pharmaceutical sales representatives, and the cost of prescribing.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

The accuracy of drug information from pharmaceutical sales representatives

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855692

Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives

27 November 2018

1 reference

12 December 2020

The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities

1 reference

12 December 2020

Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion

1 reference

12 December 2020

Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study

1 reference

12 December 2020

Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial

1 reference

12 December 2020

Reasons for not seeing drug representatives. Drug representatives have much to offer

1 reference

12 December 2020

One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial

1 reference

12 December 2020

Attention to 'details': etiquette and the pharmaceutical salesman in postwar American

1 reference

12 December 2020

Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices

1 reference

12 December 2020

The role of commercial sources in the adoption of a new drug

1 reference

12 December 2020

Doctors, drug companies, and gifts

1 reference

12 December 2020

Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff

1 reference

12 December 2020